THE WHY HOW DO COMPANY, Inc. Logo

THE WHY HOW DO COMPANY, Inc.

A corporate regeneration platform for business turnarounds, M&A, and succession solutions.

3823 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
新宿区愛住町22
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

THE WHY HOW DO COMPANY, Inc. operates a multifaceted 'corporate regeneration platform' focused on fostering mutual growth for companies and their personnel. The company's strategic business model centers on three core areas: conventional business turnarounds, innovative 'non-sale business succession' solutions, and functioning as a 'business model general trading company.' Through these services, it aims to establish a unique position as a comprehensive developer within the M&A industry, prioritizing value creation and sustainable growth. Historically known as Acrodea Inc., its operations also encompass software development, IoT solutions, and entertainment-related businesses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 09:08
Board/Management Information
臨時報告書
Japanese 21.7 KB
2025-07-14 09:46
Legal Proceedings Report
臨時報告書
Japanese 18.9 KB
2025-05-27 09:37
Board/Management Information
臨時報告書
Japanese 19.4 KB
2025-04-14 08:49
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-04-14 08:47
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-04-14 08:45
Interim Report
半期報告書-第21期(2024/09/01-2025/08/31)
Japanese 294.3 KB
2025-01-29 07:42
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-01-14 08:09
Regulatory News Service
臨時報告書
Japanese 19.4 KB
2024-11-29 08:43
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-11-29 08:41
Registration Form
確認書
Japanese 8.1 KB
2024-11-29 08:40
Governance Information
内部統制報告書-第20期(2023/09/01-2024/08/31)
Japanese 25.1 KB
2024-11-29 08:37
Annual Report
有価証券報告書-第20期(2023/09/01-2024/08/31)
Japanese 1.3 MB
2024-11-13 07:32
Annual Report
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 1.4 MB
2024-10-18 10:13
Regulatory News Service
臨時報告書
Japanese 20.9 KB
2024-08-15 08:22
Regulatory News Service
訂正有価証券報告書-第15期(2018/09/01-2019/08/31)
Japanese 675.6 KB

Automate Your Workflow. Get a real-time feed of all THE WHY HOW DO COMPANY, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for THE WHY HOW DO COMPANY, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.